An affordable, pan-genotypic (Velakast) Sofosbuvir/Velpatasvir treatment for Hepatitis C by Aprazer Healthcare
Sofosbuvir/Velpatasavir (Velakast) is a clinically proven, synergistic combination effective against all major genotypes (1-6) of the hepatitis C virus.
Velakast (Sofosbuvir/Velpatasavir), manufactured by Aprazer Healthcare, delivers an affordable Hepatitis C treatment regimen worldwide.
Aprazer Healthcare (pharmaceutical manufacturer) specializes in manufacturing generic hepatitis C medicines.
We are the largest exporter of hepatitis C medicines from India.
With global-standard drug manufacturing capabilities, we are a trusted, reliable pharmaceutical partner for international drug supplies.
Trusted worldwide by government health bodies, we supply Hepatitis C medicines to the leading global hospitals and clinics.
Why Sofosbuvir/Velpatasavir (Velakast) is widely prescribed?
It is a globally available strong antiviral combination used to treat tougher cases.
It can be safely used in children above 6 years of age and adults.
It is used in both compensated and decompensated liver cirrhosis.
Sofosbuvir/Velpatasavir (Velakast) combination benefits –
- The average cure rate is 90-95 percent.
- It offers a high resistance barrier.
- Effective against all types of mutated strains
- Widely preferred in advanced liver diseases
- Single dose combination helps easy adherence.
Velakast usage in co-infections (Hepatitis B /HIV)
It can be used safely in HIV co-infections.
However, in Hepatitis B co-infections, it cannot be used alone.
It can lead to hepatitis B reactivation.
It must be used in combination with Hepatitis B medicines.
What is Sofosbuvir/Velpatasavir (Velakast) standard dose, and how long is the treatment?
The treatment duration depends upon the overall liver health.
The standard treatment lasts for 12 weeks.
In stable cirrhosis, a single tablet (sofosbuvir -400, velpatsavir -100) once a day is used.
For advanced liver disorder, treatment can extend to 24 weeks.
For children, the dose is adjusted as per body weight.
The safe use of Sofosbuvir/Velpatasavir (Velakast) with Ribavirin –
- Dual drug regimen –
It is used as a single-dose pill, taken once for 12 weeks in people without cirrhosis or stable compensated cirrhosis.
- Triple drug regimen –
It is combined with Ribavirin and is used in advanced liver cirrhosis.
Ribavirin maximizes the cure.
It induces self-destruction of the virus.
When is Sofosbuvir/Velpatasavir (Velakast) unsafe in pregnancy?
It is not usually prescribed in pregnancy.
It can be used in conditions of high viral load to prevent transmission to the child.
The triple drug regimen adding ribavirin is highly contraindicated in pregnancy.
It can lead to severe birth defects.
Sofosbuvir/Velpatasavir (Velakast) can cure Hepatitis C. How?
It can achieve 98 percent viral elimination.
One must strictly adhere to the treatment regimen.
Complete the full course.
Do not skip the doses.
Take the medicine at the same time.
Definitive treatments for Hepatitis C by Aprazer Healthcare
